Released: 08/27/2021 Expires: 02/28/2023 (subject to change)
CE for this activity will not be available after this date.
Overview Although more than a hundred years have passed since the 1918 influenza pandemic, the haunting similarities to the ongoing COVID-19 pandemic serve as a reminder of the necessity to maintain effective influenza prevention and treatment efforts, particularly during annual flu seasons. This monograph activity contains text, infographics, tables, and case studies to review influenza prevention and treatment.
Explain the importance of every eligible patient receiving an influenza vaccination.
Choose an appropriate evidence-based communication style to communicate with vaccine hesitant patients.
Identify tools to recruit patients to get their influenza vaccination.
Contrast efficacy and benefits of antiviral treatment for influenza vs. non-treatment.
Select appropriate patients for antiviral treatment and chemoprophylaxis with antivirals.
Identify methods for differentiating influenza from SARS-CoV-2 and other influenza like illness including testing.
Speakers Ruth Carrico, PhD, DNP, FNP-C, CIC, FSHEA, FNAP Reviewer: Dawn D. Balcom, DNP, APRN, FNP-C
Disclosure This program was planned in accordance with AANP CE Standards and Policies.
Dr. Carrico discloses the following:
Pfizer: advisory board and research support
Sanofi: research support and speakers bureau
Johnson & Johnson/ Janssen: research support
Dr. Balcom has nothing to disclose.
All Planners involved in this activity have no relevant financial relationships to disclose. This activity is supported by independent educational grants from Seqirus and Genentech, a member of the Roche Group.
Disclaimer Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the Pretest associated to the activity.
Complete the educational content:
Monograph Presentations: Click the Play button to get access to the downloadable PDF monograph of the activity. Learners will be required to read all presented material in the PDF.
Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
After completing all content, click on the blue Next Steps button:
Complete the affidavit confirming that you've reviewed all required content for the activity.
Complete the post-test.
Submit the evaluation to receive full AANP CE/Rx credit.
Additional Information For questions or more information concerning this online CE opportunity contact the AANP CE Center Manager at CECenter@aanp.org.
1 Contact Hour(s) of CE, 0.5 of which may be applied towards Pharmacology